MVA Members

ReceptorPharma AB

ReceptorPharma is a young orphan receptor drug discovery company that is developing new drug candidates for neurodegenerative disorders, by utilizing recent discoveries in the expanding field of orphan G Protein-Coupled Receptor (GPCR) pharmacology and combining them with new knowledge into neurodegenerative disease mechanisms.Our long-term goal is to create new medicines for many more disease states, using the therapeutically underutilized family of orphan GPCRs as drug targets. Literature searches suggest that 80% of all orphan GPCRs, of which there still are about 80-100 in the human genome, are strongly correlated to disease. This makes them highly interesting to us and we consider them the drug targets of tomorrow.